Singapore: Astellas Pharma is constructing a new building at the Takahagi Technology Center in Japan. The building, whic...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Dr Christie Hunter, director of proteomics applications of AB Sciex, has received the 2013 Science and Techno...
Singapore: Drug major, Sanofi has received approval of Japan's Ministry of Health, Labour and Welfare (MHLW) for manufac...
Singapore: A diaphanous plastic sheet peppered with sensors could lead to the development of medical implants so unobtru...
Singapore: Shimadzu Asia Pacific, a subsidiary of Shimadzu, Japan, has appointed Mr Kiminobu Imura as its new managing d...
Singapore: Novartis Pharma and Eisai have agreed to terminate their co-promotion agreement for three therapies for chro...
New Delhi: Daiichi Sankyo's subsidiary Daiichi Sankyo Venezuela will begin marketing products of Ranbaxy in Venezuela as...
Singapore: Japan-headquartered Astellas Pharma, a global pharmaceutical company, will implement revisions in its global...
Singapore: Japan-based Daiichi Sankyo has launched antihypertensive franchise olmesartan medoxomil in Mexico under the n...
Singapore: Alnylam Pharmaceuticals and Genzyme, a Sanofi company, announced that they have formed an exclusive alliance...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Israel-based ARGO Medical Technologies has partnered with innovative robotics experts Yaskawa Electric, Japan...
On May 13, 2013, Indian drug major Ranbaxy pleaded guilty to charges related to drug safety. The company admitted to hav...
Singapore: The boards of directors of Otsuka Pharmaceutical and Astex Pharmaceuticals have unanimously approved a transa...
Singapore: Takeda, AstraZeneca, Mitsubishi Tanabe and Eisai submitted a joint application to Japan's Ministry of Health...
Singapore: Japanese company, Takeda Pharmaceutical is looking to acquire Inviragen for an upfront payment of $35 million...
Singapore: Though its surface has been turned to carbon, the bunny-like features can still be easily observed with a mic...
Singapore: Japanese companies Dainippon Sumitomo Pharma and Takeda Pharmaceutical have obtained approval for marketing a...
Singapore: Medgenics received a Notice of Allowance from the Japanese Patent and Trademark Office for key claims protec...
Singapore: Pfizer Japan and Takeda Pharmaceutical have launched Xeljanz (tofacitinib citrate) in Japan. The medicine was...
Singapore: Japanese companies are keen to collaborate with pharmaceutical companies in India. A delegation of pharmaceut...
Singapore: Japan's Astellas Pharma has collaborated with US-based Ambrx for the discovery and development of novel antib...
Singapore: Japan-headquartered Eisai and its diagnostics business subsidiary Eidia have decided to dissolve and absorb t...
Singapore: Shimadzu UK has launched a high-end liquid chromatography mass spectrometer, the LCMS-8080, which delivers be...
Singapore: Takeda Pharmaceutical submitted a marketing authorization application (MAA) to the European Medicines Agency ...
Singapore: St Jude Medical, a global medical device company, has received approval from the Japanese Ministry of Health,...
In South Korea, two research teams led by Prof. Park Se-pill at Jeju National University Stem Cell Research Center and M...
Singapore: Exlites Holdings from the US has entered into an agreement with a company that will source new cutting edge m...
Singapore: New Zealand-based dairy biotechnology company, Quantec, announced that it has signed a distribution and suppl...
Singapore: Japan-based Otsuka Pharmaceutical and H Lundbeck have received US FDA approval for Abilify Maintena (aripipra...
Singapore: The US Food and Drug Administration (FDA) has issued guidance to the Active Pharmaceutical ingredient industr...
Singapore: Dezima Pharma, a biotechnology company developing innovative drugs in the field of dyslipidemia, has in-licen...
Singapore: Eisai's South Korean sales subsidiary has received approval from the regulatory authorities in South Korea to...
Singapore: The former executives and shareholders of Takeda, a leading Japanese firm, have expressed their resentment ov...
Singapore: Swedish specialty pharmaceutical company, Orexo, revealed that that its partner Kyowa Hakko Kirin submitted ...
Singapore: Eisai revealed its preliminary results from a recently completed phase III study of Halaven versus capecitabi...
Singapore: Six current and former female pharmaceutical sales professionals working with Daiichi Sankyo, US, have filed ...
Singapore: Takeda Pharmaceutical's wholly-owned subsidiary, Takeda America, and Envoy Therapeutics have entered into a ...
Singapore: The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a...
Singapore: Abbott Japan and Eisai have received approval from Japan's Ministry of Health, Labor and Welfare to market Hu...
Singapore: Daiichi Sankyo's 24-month randomized, double-blind, placebo-controlled multi-center phase III clinical trial ...
Singapore: The Japanese Ministry of Health, Labor and Welfare has approved a new drug application (NDA) of Lotriga granu...
Singapore: Initial results received from the phase III SINGLE (ING114467) study of Shionogi-ViiV Healthcare's investigat...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The Foreign Investment Promotion Board (FIPB) has cleared seven out of the ten investment proposals in the ph...
Singapore: Kyoto University has been granted four patents relating to its basic iPS cell technology, one in Japan and th...
Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo have announced that Mitsubishi Tanabe Pharma has received approva...
Singapore: Japan-based Astellas Pharma has submitted a European marketing authorization application to the European Medi...
Singapore: Daiichi Sankyo has submitted a supplemental new drug application to Japan's Ministry of Health, Labor and Wel...
Singapore: Tokyo-based Astellas, a pharmaceutical company, is investing $140 million to locate its headquarters for the ...
Singapore: Mr Sergey Brin (computer scientist and co-founder of Google), Ms Anne Wojcicki (American biologist, co-founde...
Singapore: The agriculture ministry of Japan will set up a center to develop rice strains, using genetic studies, that a...
New Delhi: Daiichi Sankyo and Ranbaxy will work in synergy in Brazil to expand the business of both companies in the cou...
Singapore: Japan's technology company, Arkray is investing $9.1 million over a five-year period in a research venture an...
Singapore: Fujifilm Corporation has started full-scale operation of Fujifilm Optics Philippines in Laguna. The new compa...
Singapore: National Cancer Center of Japan and pharma company Daiichi Sankyo have agreed to form a comprehensive resear...
Singapore: Australian drug delivery technology company Phosphagenics has extended its collaboration with its high calib...
Singapore: BIOtech 2013 in Japan, which is one-of-the-largest bio events in Asia, concluded successfully. The event was ...
Singapore: Mystic Pharmaceuticals, US, received key notices of allowance from Asian patent offices in the company's ong...
‎Singapore: TriReme Medical's Japanese partner, Century Medical, has received Shonin approval for Glider PTCA cath...
The Nobel prize for Physiology to two stem cell research scientists in 2012 has firmly put the spotlight on this promisi...
Singapore: Ariad Pharmaceuticals, an emerging global oncology company focused on discovery, development and commercializ...
Singapore: Eisai has been able to meet the US FDA's written request requirements for pediatric exclusivity for Aciphex ...
Singapore: Abbott announced that it has initiated the Absorb Japan randomized controlled clinical trial to evaluate the ...
Singapore: Japanese multinational Chugai Pharmaceutical has filed a new drug application to the Ministry of Health, Labo...
Singapore: Dr Shinya Yamanaka, director of the Center for iPS Cell Research and Application (CiRA), Kyoto University, ha...
Singapore: Chugai Pharma USA, Berkeley Heights, NJ a wholly owned subsidiary of Chugai Pharmaceutical, Tokyo, Japan, mem...
Singapore: Japan is hosting its first personalised medicine and diagnostics expo in May 14-16, 2014.The Japanese governm...
The aging population in Japan is not only driving the medical care and pharmaceutical industry but also the medical devi...
Singapore: Eribulin, an anticancer drug marketed by Japan-based Eisai under the trade name Halaven, has received reimbur...
Singapore: Eisai has decided to launch its AMPA receptor antagonist Fycompa (perampanel), a first-in-class anti-epilepti...
The pioneering research of Nobel Laureates Sir John Gurdon and Dr Shinya Yamanaka on reprogramming adult stem cells has ...
Singapore: Takeda Global Research and Development, a wholly owned subsidiary of Takeda Pharmaceutical, has filed seven n...
Singapore: Takeda Pharmaceutical and its wholly-owned subsidiary, Takeda Pharmaceuticals USA, have announced that the US...
New Delhi: Aiming at becoming one of the global manufacturing hubs, besides being a large healthcare market, India has i...
Singapore: Japan's top pharma companies, including Astellas, Eisai, Daiichi Sankyo, Shionogi, and Takeda, have come toge...
Singapore: The WHO has prequalified Eisai's drug NTD002, a 100 mg tablet of diethylcarbamazine (DEC) for treatment of el...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: The wholly-owned US subsidiary of Sysmex, Sysmex America, has won the seventh annual Pinnacle Award presented...
Singapore: Mr Yoshihiro Arai, currently general manager and head of development of Solasia Pharma, has been promoted to...
Singapore: Medical Device and Diagnostic Industry (MD+DI) recently published an original infographic and supporting arti...
Singapore: The intellectual property and science business of Thomson Reuters has collaborated with Japan's Tohoku Univer...
Singapore: Proteus Digital Health and Otsuka Pharmaceutical, a subsidiary of Japan-headquartered Otsuka Group, have ente...
Singapore: Swiss chemicals and drug company Lonza and USA-based BioWa, a wholly-owned subsidiary of Japan's Kyowa Hakko ...
Singapore: A joint panel of members from the Gastrointestinal Drugs and Drug Safety and Risk Management Advisory Committ...
Singapore: Harlan Contract Research Services (CRS), a division of Harlan Laboratories, a privately held provider of gene...
Singapore: Accuray, a radiation oncology company, has extended its industry-leading Emerald Service Program for the Tomo...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for...
Big pharma companies are gearing up to combat the shortage of injectables in the US through acquiring companies with app...
Singapore: In an internal probing by the Novartis Pharma, it was revealed that its employees in Japan had failed to repo...
Singapore: AB SCIEX, a global leader in life science analytical technologies, announced a global initiative focused on ...
Singapore: Eisai's US subsidiary Morphotek has opened a new pilot manufacturing plant in Exton, Pennsylvania, for the pr...
Singapore: Japan's largest research organization, Riken has launched two virtual Joint Research Centers with India's pre...
Singapore: Japanese firm, Mitsubishi Electric Corporation, is gearing up to solidify its presence in the bioscience sect...
Singapore: Daiichi Sankyo received approval for a supplemental new drug application (sNDA) for an additional indication ...
Singapore: Daiichi Sankyo and Ranbaxy Laboratories will integrate their business operations in Thailand, in order to lev...
Singapore: The wholly owned subsidiary of Japan-based Takeda Pharmaceutical, Takeda America Holdings, has entered into a...
